Hideaki Nagase

Cancer Research · 1999–2015

A researcher in the Science corpus: 10 papers; trusts 7 researchers and is trusted by 8 researchers here, as inferred from the citation graph.

Subfields

• Cancer Research — 44 citations into it; #318 of 1,780 by trust here, #496 by citations
• Oncology — 31 citations into it; #497 of 1,698 by trust here, #752 by citations
• Molecular Biology — 27 citations into it; #4,860 of 17,773 by trust here, #4,912 by citations
• Hematology — 20 citations into it; #137 of 225 by trust here, #84 by citations
• Pulmonary and Respiratory Medicine — 8 citations into it

Whom Hideaki Nagase trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. A. Newby
2. R. Visse
3. Gillian Murphy
4. D. Edwards
5. K. Brew
6. A. Baker

Who trusts Hideaki Nagase overall

1. Gillian Murphy
2. M. Xue
3. Xi Wang
4. C. Jackson
5. R. Khalil
6. Hao-Hsiu Huang
7. Francis G. Spinale
8. K. Brew
9. T. Cox
10. A. Berrier

Papers from Hideaki Nagase's perspective

Ordered by how strongly the researchers Hideaki Nagase trusts endorse each paper. Same corpus, a different order for every researcher.

1. S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death (Science)
2. How matrix metalloproteinases regulate cell behavior. (Annual Review of Cell and Developmental Biology)
3. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. (Journal of Clinical Investigation)
4. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
5. Tissue inhibitors of metalloproteinases: evolution, structure and function. (Biochimica et Biophysica Acta)
6. TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)*
7. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. (Cell)
8. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. (Physiological Reviews)
9. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry (Circulation Research)
10. Matrix metalloproteinases and the regulation of tissue remodelling (Nature reviews. Molecular cell biology)

Their papers

• Structure and function of matrix metalloproteinases and TIMPs. (2006) — 3,321 citations
• TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)* (2001) — 538 citations
• The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity (2010) — 1,318 citations
• Progress in matrix metalloproteinase research. (2008) — 743 citations
• Metalloproteinase‐dependent and ‐independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs‐15 (2015) — 51 citations
• Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2) (2010) — 39 citations
• Sulfated Glycosaminoglycans Control the Extracellular Trafficking and the Activity of the Metalloprotease Inhibitor TIMP-3 (2014) — 77 citations
• The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3 (2009) — 65 citations
• TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2. (2006) — 103 citations
• Cloning and Characterization of ADAMTS11, an Aggrecanase from the ADAMTS Family* (1999)